Cell-free DNA whole genome sequencing as a uniting force for cancer detection, diagnostics, and monitoring
As part of our LMP Seminar Series we are delighted to welcome our speaker:
Dr. Trevor Pugh, PhD
Canada Research Chair in Translational Genomics
Senior Scientist, Princess Margaret Cancer Centre, University Health Network
Director, Innovation, Laboratory Medicine Program, University Health Network
Director and Senior Investigator, Genomics, Ontario Institute for Cancer Research
Professor, Department of Medical Biophysics, University of Toronto
Talk title: "Cell-free DNA whole genome sequencing as a uniting force for cancer detection, diagnostics, and monitoring"
Hosted by
How to join
The event will be in person, no need to register. Students and trainees must attend in person.
For faculty members who need to attend remotely, please register to receive the zoom link. Registration must be received by noon on Tuesday.
If you have any questions, please contact lmp.chairadmin@utoronto.ca for more details.
Wednesday, January 28, 2026
11 am - 12 pm
MSB 2170
Medical Sciences Building
University of Toronto
1 King’s College Circle
Toronto, ON M5S 1A8
Details are sent to the LMP community in the Friday events bulletin.
Speaker bio: Dr. Trevor Pugh, PhD
Trevor J. Pugh, PhD, is a Canada Research Chair in Translational Genomics and Professor in the Department of Medical Biophysics at the University of Toronto. He is a Senior Scientist at Princess Margaret Cancer Centre, Director of Genomics at the Ontario Institute for Cancer Research, and Director of Innovation for the University Health Network Laboratory Medicine Program. He leads a translational genomics program focused on linking cancer genome alterations to clinical outcomes, monitoring dynamic changes in cancer and immune cell populations during treatment, and enabling comprehensive genomics as a routine medical test. His team profiles tumours and blood using cell-free DNA, immune repertoire, single-cell, and whole-genome sequencing, and develops software platforms to support global data sharing. His work advances the knowledge base and infrastructure required to deliver genomic medicine to cancer patients worldwide.
